Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PDSB
#4373
PDS Biotechnology Corporation - Common Stock
0.7
4
USD
-0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.33%
Monthly Change
-25.25%
6 month change
-22.11%
Year Change
-35.65%
Previous Close
0.7
5
Open
0.7
4
Low
0.7
4
High
0.7
5
Volume
69
Markets
US Stock Market
Healthcare
Biotechnology
PDSB
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
TTM
Cash from operating activities
-9.03 M
-9.1 M
-5.92 M
-3.7 M
-4.37 M
-23.09 M
Cash from investing activities
—
—
0
0
—
—
Cash from financing activities
7.32 M
995.94 K
241.2 K
4.22 M
-679.83 K
4.77 M
Free cash flow
-9.03 M
-9.1 M
-5.92 M
-3.7 M
-4.37 M
-23.09 M
News
Here's Why PDS Biotechnology (PDSB) Could be Great Choice for a Bottom Fisher
PDS Biotechnology Corporation (PDSB) Q4 2025 Earnings Call Transcript
VTSAX vs. VTI: Which Vanguard Fund Should You Buy in 2026? - TipRanks.com
PDS Biotechnology receives Nasdaq notice for minimum bid price deficiency
VOO vs. VTI: Which Vanguard ETF Is the Smarter Buy for 2026? - TipRanks.com
PDS Biotech amends Phase 3 trial to add accelerated approval path
PDS Biotech reports 9.6-month progression-free survival in prostate cancer study
PDS Biotech secures patent for cancer immunotherapy PDS0101
PDS Biotech stock soars after FDA meeting provides accelerated approval path
PDS Biotech submits amended protocol for phase 3 cancer trial
PDS Biotech secures new patent for cancer immunotherapy in Japan
PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why